Yusuke Goto

35PUBLICATIONS
31CO-AUTHORS
Molecular targetsChiropracticPredictive and prognostic markersRespiratory diseasesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jul 28, 2026
MEK1 as a Synthetic Lethal Target with Cabozantinib in Renal Cell Carcinoma: Insights from CRISPR/Cas9 Screening.

|Jan 16, 2026
Renal Granuloma Distinct From the Renal Pelvis Following Bacillus Calmette-Guérin Treatment for Bladder Cancer: A Case Report.

Ryuji Oka, Yusuke Goto, Kosuke Mikami

|Jan 08, 2025
Time to Castration Resistance is Associated With Overall Survival Even After the Achievement of Castration Resistance in Metastatic Prostate Cancer.

Hiroto Kato, Yusuke Goto, Satoko Kojima

|Oct 28, 2024
Oncogenic HRAS Induces Metformin Resistance in Head and Neck Cancer by Promoting Glycolytic Metabolism.

Xingyu Wu, Sendi Rafael Adame-Garcia, Keiichi Koshizuka

|Sep 28, 2024
Identification of Tumor Suppressive miR-144-5p Targets: FAM111B Expression Accelerates the Malignant Phenotypes of Lung Adenocarcinoma.

Yuya Tomioka, Naohiko Seki, Takayuki Suetsugu

|Jul 02, 2024
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC.

Yusuke Goto, Keiichi Koshizuka, Toshinori Ando

Pageof 6

Frequent Collaborators

5 joint publications

Naohiko Seki

5 joint publications

Tomokazu Sazuka

3 joint publications

Shinichi Sakamoto

3 joint publications

Hiroaki Sato